Manufacturer:

Amgen

Name:

IMLYGIC

Category:

J Code

HCPCS:

J9325

NDC(s):

55513-0078-01, 55513-0079-01,

Primary Type:

Cancer

Route of Administration:

Injection

About:

IMLYGIC is a Cancer drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J9325 is aligned to the drug IMLYGIC.